Octozi

Octozi has developed an AI-powered platform that automates and streamlines the cleaning, review, and management of clinical trial data across all phases. The solution leverages generative artificial intelligence—including custom large language models—to reduce manual effort, minimize errors, accelerate regulatory submissions, improve patient safety through early signal detection, and enable real-time discrepancy identification. The company partners with biopharma sponsors to increase speed to market for new therapies by making clinical development workflows more efficient. No direct clinical results as it is not a therapeutic developer.